Campbell & CO Investment Adviser LLC

Position in AMGN — Amgen Inc

CIK 1353570 BALTIMORE, MD

Position in AMGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,964,603

+$135,472 QoQ

Shares Held

14,110

-4.4% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.28%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Campbell & CO Investment Adviser LLC holds $29,502,691 across 9 Drug Manufacturers - General names. AMGN ranks #4 (16.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	GILD	Gilead Sciences, Inc.	50,560	$7,046,547
2	LLY	ELI LILLY & Co	7,041	$6,476,100
3	NVS	Novartis AG	39,646	$6,055,926
4	AMGN	Amgen Inc This page	14,110	$4,964,603
5	BMY	Bristol Myers Squibb Co	29,424	$1,784,565
6	AZN	Astrazeneca PLC	8,338	$1,644,420
7	OGN	Organon & Co.	128,309	$768,570
8	GRFS	Grifols SA	63,848	$512,060

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,964,603	14,110	-4.4%	Shares	Sole	2026-05-15
2025-12-31	$4,829,131	14,754	+289.8%	Shares	Sole	2026-02-12
2025-09-30	$1,068,127	3,785	-72.7%	Shares	Sole	2025-10-28
2025-03-31	$4,318,394	13,861	-32.9%	Shares	Sole	2025-05-14
2024-12-31	$5,382,216	20,650	+110.9%	Shares	Sole	2025-02-10
2024-09-30	$3,155,402	9,793	+319.9%	Shares	Sole	2024-11-12
2024-06-30	$728,633	2,332	+4.4%	Shares	Sole	2024-08-13
2024-03-31	$635,170	2,234	+37.6%	Shares	Sole	2024-05-10
2023-09-30	$436,466	1,624	-78.9%	Shares	Sole	2023-11-08
2022-12-31	$2,019,438	7,689	+287.4%	Shares	Sole	2023-02-14
2022-06-30	$482,950	1,985	-36.4%	Shares	Sole	2022-08-09
2021-09-30	$663,255	3,119	—	Shares	Sole	2021-11-10
No filing history on record for this holder in this stock.